Advancing A Novel Therapeutic Lead for RASopathies
Awardee: Bruce Gelb
Institution: Icahn School of Medicine at Mount Sinai
Award Amount: $74,830
Funding Period: February 1, 2019 - January 31, 2020
Previous
Previous
Role of the GM-CSF Pathway in Heterotypic Ossification Associated with FOP
Next
Next